(Q44910304)

English

Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

7

object named as

Anna Taddio

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

L Lee Dupuis

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Lillian Sung

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Tracey Taylor

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Mohamed Abdolell

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Upton Allen

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

John Doyle

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

564-573

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical issues surrounding once-daily aminoglycoside dosing in children

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Pharmacokinetic analysis of gentamicin thrice and single daily dosage in pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia i

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Once daily antibiotic regimen in paediatric oncology

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Clinical pharmacology of tobramycin in children

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

A dose-ranging study of gentamicin pharmacokinetics: implications for extended interval aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Once-daily versus multiple-daily gentamicin in infants and children

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Aminoglycoside dosages and nephrotoxicity: quantitative relationships

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.564.34743

21 January 2018

Identifiers

10.1592/PHCO.24.6.564.34743

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_qf5gp3he5veixk5tzcfmazng44

1 reference

https://api.fatcat.wiki/v0/release/qf5gp3he5veixk5tzcfmazng44

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44910304&oldid=2143444979"